We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Alliance for Cytometric Tissue Analysis

By Labmedica staff writers
Posted on 09 May 2005
A new agreement has been announced whose terms will allow Asterand (Detroit, MI, USA) to include a quantitative cytometric analysis of tissue and tissue microarrays by CompuCyte Corp. More...
(Cambridge, MA, USA) as part of its molecular pathology services.

Asterand stated that this is a natural extension of the company's molecular pathology contract research service, which specializes in immunohistochemistry and RNA in situ hybridization studies, using human tissue samples assembled into tissue microarrays selected from its global biorepository of clinically obtained specimens. The availability of a quantitative cytometric sample analysis, in addition to classic pathology assessment, provides an added benefit of complete objectivity and increased analytic throughput.

CompuCyte is a global company, whose iGeneration imaging cytometers allow simultaneous quantitative analysis of fluorescently and chromatically stained tissue sections. Exclusive image processing techniques correct for background fluorescence and spectral overlap of both fluorescent dyes and chromophores, and the resulting high-resolution images are archived for assay validation. The technology permits visualization and quantification of cellular processes that may not be observable through microscopy alone.

"We have many customers who are looking to quantify differences in protein or RNA expression between diseased and normal tissue,” said Dr. Victoria Blanc, director of research services at Asterand. "The addition of this service will assist our customers in their data analysis and interpretation of results.” Asterand is a leading provider of human tissue for genomic and proteomic research. The company acquires donated samples from a worldwide network of collaborating hospitals and clinics.





Related Links:
Asterand
CompuCyte

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.